Evaluation of Lotrafilcon A Lenses Over a Three Month Period

Ciba Vision

Status: Completed

Conditions: Myopia

Treatments: Device: Lotrafilcon A contact lens

Study type: Interventional

Funder types: Industry

Identifiers

NCT00931307

P-335-C-013

Details and patient eligibility

About

The purpose of this trial is to assess the performance of a Lotrafilcon A contact lens over a 3-month period.

Enrollment: 22 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• On examination, have ocular findings considered to be "normal" and which would not prevent a subject from safely wearing contact lenses.
• Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent.
• Be able to wear the study lenses in the available powers.
• Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
• Other protocol inclusion/exclusion criteria may apply.

Exclusion criteria

• Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial.
• Pre-existing ocular irritation that would preclude contact lens fitting.
• Currently enrolled in an ophthalmic clinical trial.
• Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
• Any use of medications for which contact lens wear would be contraindicated, in the opinion of the investigator.
• History of corneal refractive surgery.
• Other protocol inclusion/exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Lotrafilcon A

Experimental group

Treatment:

Device: Lotrafilcon A contact lens